appendix 7: Ovarian cancer: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Gynaecological-Malignancies)-Reference-Cited by-同舟云学术

appendix 7: Ovarian cancer: eUpdate published online September 2016 (http://www.esmo.org/Guidelines/Gynaecological-Malignancies)

Published:2016-09 Issue: Volume:27 Page:v145
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ledermann J.A.,Sessa C.,Colombo N.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/27/suppl_5/v145/6679820/mdw360.pdf

Reference6 articles.

1. Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial;Ledermann;Lancet Oncol,2014

2. Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: An updated analysis from a Phase II, randomised, double-blind, placebo-controlled trial;Ledermann;Lancet Oncol,2016

3. The contribution of BRCA1 and BRCA2 to ovarian cancer;Ramus;Mol Oncol,2009

4. BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group;Alsop;J Clin Oncol,2012

5. Underestimation of risk of a BRCA1 or BRCA2 mutation in women with high-grade serous ovarian cancer by BRCAPRO: a multi-institution study;Daniels;J Clin Oncol,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-grade serous carcinoma of the fallopian tube in a young woman with chromosomal 4q abnormality: A case report;World Journal of Clinical Cases;2024-06-26

2. MRI in female pelvis: an ESUR/ESR survey;Insights into Imaging;2022-03-28

3. Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service;Clinical Therapeutics;2020-07

4. “Lower abdominal pains, as if I was being squeezed…in a clamp”: A Qualitative Analysis of Symptoms, Patient-Perceived Side Effects and Impacts of Ovarian Cancer;The Patient - Patient-Centered Outcomes Research;2019-11-06

5. BRCAmutation testing for ovarian cancer in the context of available targeted therapy: Survey and consensus of Hong Kong specialists;Asia-Pacific Journal of Clinical Oncology;2019-03